Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Doxazosin 4mg tablets
0205040D0AAACAC
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 425,711 |
|
Doxazosin 2mg tablets
0205040D0AAABAB
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 363,029 |
|
Doxazosin 1mg tablets
0205040D0AAAAAA
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 218,775 |
|
Doxazosin 8mg tablets
0205040D0AABBBB
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 56,030 |
|
Doxazosin 4mg modified-release tablets
0205040D0AAAQAQ
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 38,745 |
|
Doxazosin 8mg modified-release tablets
0205040D0AAARAR
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 30,955 |
|
Doxazosin 4mg/5ml oral solution
0205040D0AAAXAX
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 268 |
|
Doxazosin 1mg/5ml oral solution
0205040D0AAAZAZ
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 127 |
|
Doxazosin 1mg/5ml oral suspension
0205040D0AABABA
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 56 |
|
Doxazosin 4mg/5ml oral suspension
0205040D0AAAYAY
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 42 |
|
Doxazosin 16mg/5ml oral suspension
0205040D0AAAWAW
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 2.5mg/5ml oral liquid
0205040D0AAATAT
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 2mg/5ml oral liquid
0205040D0AAAIAI
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 3mg/5ml oral liquid
0205040D0AAAPAP
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 4mg capsules
0205040D0AAAFAF
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 500micrograms/5ml oral liquid
0205040D0AAAUAU
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 5mg/5ml oral liquid
0205040D0AAAKAK
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 6mg/5ml oral liquid
0205040D0AAASAS
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 80mg/5ml oral liquid
0205040D0AAAVAV
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 8mg/5ml oral liquid
0205040D0AAAHAH
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.